A Novel Co-Operative Mechanism Linking TGFβ And Lyn Kinase Activation to Imatinib Resistance in Chronic Myeloid Leukaemia Cells

Oncotarget - United States
doi 10.18632/oncotarget.500
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Gynaecomastia in Men With Chronic Myeloid Leukaemia After Imatinib

The Lancet
Medicine
2003English

Adhesion to Stromal Cells Mediates Imatinib Resistance in Chronic Myeloid Leukemia Through ERK and BMP Signaling Pathways

Scientific Reports
Multidisciplinary
2017English

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients With Chronic Myeloid Leukaemia

PLoS ONE
Multidisciplinary
2017English

The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal

British Journal of Haematology
Hematology
2017English

Factors Influencing Long-Term Efficacy and Tolerability of Bosutinib in Chronic Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib

British Journal of Haematology
Hematology
2015English

Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients

Hematology Reports
Hematology
2012English

Chronic Myeloid Leukaemia and Pregnancy

BMJ
1950English

Long-Term Impact of Molecular Response Fluctuations in Chronic Myeloid Leukaemia Patients Treated With Imatinib

British Journal of Haematology
Hematology
2017English

Stochastic Modelling of Tyrosine Kinase Inhibitor Rotation Therapy in Chronic Myeloid Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy